CD274 and pancreatic neoplasm: A recent study reported benefits of CAR T cell therapy combined with an oncolytic adenovirus and a helper-dependent adenoviral vector encoding IL-12 and a PD-L1 blocking minibody against pancreatic cancer xenografts (66).